Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression data to identify molecular characteristics of mucinous colorectal cancer

ABSTRACT: Gene expression data to identify molecular characteristics of mucinous colorectal cancer

PROVIDER: PRJNA1186176 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Gene expression data to identify molecular characteristics of mucinous colorectal cancer

Project description:Mucinous adenocarcinoma (MuC), a subtype of colorectal cancer (CRC), exhibits distinct molecular features and a poorer prognosis compared to non-mucinous CRC (NMuC). Standard CRC treatments often fail to address MuC's unique characteristics, especially in stage II, where the benefit of adjuvant chemotherapy is unclear. Biomarkers that improve risk assessment and guide personalized treatment are needed. Based on RNA-seq data and Cox regression models, we developed a signature reflecting the characteristics of MuC which showed a strong prediction ability and clinical utility in both MuC and NMuC. Our signature represents a valuable tool for predicting recurrence and guiding personalized treatment in CRC.

2025-07-02 | GSE281917 | GEO

Gene expression data of non-mucinous colorectal cancers to support to identify molecular characteristics of mucinous colorectal cancer

2025-07-02 | GSE281918 | GEO

Gene expression data of non-mucinous colorectal cancers to support to identify molecular characteristics of mucinous colorectal cancer

Project description:Gene expression data of non-mucinous colorectal cancers to support to identify molecular characteristics of mucinous colorectal cancer

| PRJNA1186177 | ENA

Mucinous colorectal adenocarcinoma

Project description:Mucinous colorectal adenocarcinoma

| PRJNA992109 | ENA

Proteome profiling of mucinous and non-mucinous colorectal cancer

Project description:Mucus is associated with poor prognosis of colorectal cancer, but its mechanism remains unclear. The aim of this study was to reveal the key proteins in mucinous colorectal cancer. In this study, high-resolution liquid chromatography tandem mass spectrometry (LC-MS / MS) combined with quantitative 6-plex tandem mass mass tag labeling was used to profile protein changes in the left and right sides of mucinous and non-mucinous colorectal cancer tissues. A total of 7432 proteins were identified and analyzed.

2020-11-28 | PXD022802 |

Spatial transcriptomics reveals functional compartmentalization of mucinous colorectal adenocarcinoma

Project description:We performed spatial transcriptomics to profile compositional and spatial distribution of hetergeneous cell populations in mucinous colorectal adenocarinoma

2024-04-28 | GSE236697 | GEO

LSD1 and CoREST2 Regulate STAT3 Activity to Promote Enteroendocrine Cell Differentiation in Mucinous Colorectal Cancer[scMultiome-seq]

Project description:Neuroendocrine cells have been implicated in therapeutic resistance and worse overall survival in many cancer types. Mucinous colorectal cancer (mCRC) is uniquely enriched for enteroendocrine cells (EECs), the neuroendocrine cell of the normal colon epithelium, as compared to non-mucinous CRC. Therefore, targeting EEC differentiation may have clinical value in mCRC. Here, single cell multi-omics was used to uncover epigenetic alterations that accompany EEC differentiation, identify STAT3 as a novel regulator of EEC specification, and discover a rare cancer-specific cell type with enteric neuron-like characteristics. Further experiments demonstrated that lysine-specific demethylase 1 (LSD1) and CoREST2 mediate STAT3 demethylation and regulate STAT3 chromatin binding. Knockdown of CoREST2 in an orthotopic xenograft mouse model resulted in decreased primary tumor growth and lung metastases. In culmination, these results provide rationale for new LSD1 inhibitors that target the interaction between LSD1 with STAT3 or CoREST2, which may improve clinical outcomes for patients with mCRC.

2024-09-19 | GSE268957 | GEO

LSD1 and CoREST2 Regulate STAT3 Activity to Promote Enteroendocrine Cell Differentiation in Mucinous Colorectal Cancer[CUT&RUN]

2024-09-19 | GSE268956 | GEO

Molecular characterization of mucinous breast cancer by low-coverage WGS

Project description:Molecular characterization of mucinous breast cancer identifies epigenetic regulation of MUC2 as a driver of the disease.

2022-02-02 | E-MTAB-7256 | biostudies-arrayexpress

Spatial transcriptomics reveals functional compartmentalization of mucinous colorectal adenocarcinoma

Project description:Spatial transcriptomics reveals functional compartmentalization of mucinous colorectal adenocarcinoma

| PRJNA992207 | ENA